The Key Importance of Screening Underprivileged People in Order to Achieve Global Hepatitis Virus Elimination Targets

The Key Importance of Screening Underprivileged People in Order to Achieve Global Hepatitis Virus Elimination Targets

Chronic hepatitis B (HBV), alongside hepatitis D virus (HDV) super-/co-infection and chronic hepatitis C (HCV), are major contributors to cirrhosis, end-stage liver disease, hepatocellular carcinoma (HCC), and liver-related mortality. Despite significant progress in antiviral treatments and HBV vacc...

Full description

Saved in:

Bibliographic Details
Main Authors:	Laura Gragnani, Monica Monti, Irene De Giorgi, Anna Linda Zignego
Format:	Article
Language:	English
Published:	MDPI AG 2025-02-01
Series:	Viruses
Subjects:	chronic hepatitis B (HBV) chronic hepatitis C (HCV) rapid screening vulnerable populations marginality
Online Access:	https://www.mdpi.com/1999-4915/17/2/265
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN
by: Anil Pathare, et al.
Published: (2019-10-01)

Comparative evaluation of APRI and MELD scores in the prediction of complications of chronic hepatitis in patients infected with hepatitis B or C viruses in Lubumbashi, democratic republic of Congo
by: Arsène Kabamba-Tshikongo, et al.
Published: (2025-02-01)

Features of clinical course of chronic hepatites of mixed viral (HBV+HCV) etiologies
by: G. K. Mirodzhov, et al.
Published: (2009-10-01)

The comparative description of clinical course, injury an regeneration of liver while chronic HBV- and HCV- infections course
by: V. E. Karev, et al.
Published: (2014-09-01)

Immunological and Virological Responses in Patients with Monoinfection and Coinfection with Hepatitis B and C Viruses in the Brazilian Amazon
by: Joseane R. Silva, et al.
Published: (2025-06-01)

CHRONIC VIRAL HEPATITIS В AND C IN CHILDREN BORN FROM MOTHERS INFECTED WITH НВV AND HCV
by: T. I. Raba
Published: (2017-03-01)

Assessment of Students Knowledge and Attitude toward Hepatitis B and C in Sohag University/Egypt
by: Ghona Abd El-Nasser, et al.
Published: (2013-04-01)

Determinants of outcomes in patients with hepatitis B virus-decompensated cirrhosis
by: Yi-Jie Huang, et al.
Published: (2025-01-01)

Targeting HBV cccDNA Levels: Key to Achieving Complete Cure of Chronic Hepatitis B
by: Wei He, et al.
Published: (2024-12-01)

Variety of the hepatitis B virus genovariants in the military
by: Yu. V. Ostankova, et al.
Published: (2019-10-01)

Diagnostic options of non-invasive assessment of fibrosis at diffuse liver diseases
by: I. Yu. Pirogova, et al.
Published: (2009-08-01)

HBV, HCV, and HDV Triple-Infection—A Therapeutic Challenge
by: Alexia Anastasia Stefania Balta, et al.
Published: (2025-05-01)

Stakeholder perspectives and the challenges in implementing hepatitis C elimination policy in Pakistan
by: Naeem Asim, et al.
Published: (2025-07-01)

Assessment of liver fibrosis stage influence on clinical course of periodontal diseases in patients with chronic hepatitis C
by: О. М. Slaba, et al.
Published: (2017-08-01)

Variety of genotypes of a HCV virus and outcomes of chronic hepatitis C: results 5 summer supervision in the territory of the Kirov region
by: S. V. Baramzina, et al.
Published: (2014-09-01)

Characterization of Hepatitis B Virus Transcripts in Chronically HBV-Infected Chimpanzees and Patients Treated with ARC-520 siRNA Demonstrates Transcriptional Silencing of cccDNA
by: Christine I. Wooddell, et al.
Published: (2024-12-01)

Pathway to hepatitis C elimination: insights from a large tertiary hospital in South China
by: Suling Chen, et al.
Published: (2025-12-01)

Correlation between virological response and portal vein thrombosis in patients with chronic hepatitis B
by: Zhanghao Li, et al.
Published: (2025-07-01)

HEPATITIS C VIRUS INFECTION AND LYMPHOMA
by: Felipe Suarez, et al.
Published: (2010-02-01)

HEPATITIS C VIRUS INFECTION AND LYMPHOMA
by: Emmanuel Bachy, et al.
Published: (2010-03-01)

Elimination of HCV Infection: Recent Epidemiological Findings, Barriers, and Strategies for the Coming Years
by: Pietro Torre, et al.
Published: (2024-11-01)

Causal relationship between hepatic function indicators and thrombocytopenia risk in early-stage hepatitis B virus infection: evidence from clinical observational studies and mendelian randomization analyses
by: Tian-bin Chen, et al.
Published: (2025-05-01)

IMMUNOLOGICAL FEATURES IN LIVER CIRRHOSIS INDUCED BY HEPATITIS B VIRUS
by: O. I. Urazova, et al.
Published: (2014-07-01)

THE SIGNIFICANCE OF QUANTITIES DETECTION OF СORE ANTIGEN IN BLOOD SERUM OF CHILDREN WITH HEPATITIS C
by: A. Leybman, et al.
Published: (2015-08-01)

Hepatitis C virus genotypes and viremia in a tertiary hospital in Istanbul, Turkey
by: Sema Alacam, et al.
Published: (2022-04-01)

Comparative Efficacy of Etiotropic Therapy of Patients with HBeAg-Positive Chronic Hepatitis B (by the Data of the International Comparative Placebo-Controlled Study)
by: V. V. Stelmakh, et al.
Published: (2020-05-01)

Immunogenicity and predictive factors of hepatitis B vaccination with Fendrix® in chronic kidney disease patients
by: Cristina Hernán-García, et al.
Published: (2025-03-01)

Seropositivity and coinfection of hepatitis B and hepatitis C viruses in Central India: A hospital-based study
by: Rajeev K. Jain, et al.
Published: (2024-10-01)

Cryoglobulinemia and hepatitis C virus
by: N. V. Dunaeva, et al.
Published: (2014-09-01)

Taurochenodeoxycholic acid as a sensitive stratification marker for HBV-associated hepatic cirrhosis status has a hepatoprotective effect
by: Jingyan Zeng, et al.
Published: (2025-08-01)

Serum hepatitis B virus RNA in low-level viremia of chronic hepatitis B: clinical features and association with virological response
by: Yongbin Wu, et al.
Published: (2025-05-01)

Detection rate of specific antibodies to the HCV CORE+1 protein in “naive” cronically HCV-infected patients in depends on the stage of liver fibrosis and the HCV subtype
by: E. V. Lichnaya, et al.
Published: (2021-01-01)

Clinical and laboratory characteristics of occult hepatitis B
by: E. V. Esaulenko, et al.
Published: (2016-04-01)

METABOLIC AND CARDIOVASCULAR COMORBIDITIES IN BULGARIAN PATIENTS WITH CHRONIC VIRAL B AND C HEPATITIS
by: Radoslava Tsrancheva, et al.
Published: (2025-01-01)

Increasing Prevalence of Occult HBV Infection in Adults Vaccinated Against Hepatitis B at Birth
by: Ge Zhong, et al.
Published: (2025-02-01)

Impact of hepatitis C virus genotype on the efficacy of the direct-acting antivirals in chronic kidney disease patients in West Bengal, India
by: Sagnik Bakshi, et al.
Published: (2025-05-01)

Range of extrahepatic implications in patients with chronic hepatitis c depending on the infection with different genotypes of the virus and the virus load
by: Yu.Yu. Ryabokon
Published: (2013-08-01)

Case-term Adverse Outcomes of Chronic Hepatitis C, Extrahepatic Manifestations of a Young Man Infected in Early Childhood
by: S. V. Baramzina, et al.
Published: (2015-12-01)

Evaluation of life quality of patients with chronic hepatitis C.
by: O. P. Schevchenko-Makarenko, et al.
Published: (2017-12-01)

Editorial: Chronic hepatitis B management: current status and future directions
by: Ivana Lazarevic, et al.
Published: (2025-06-01)